|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.640 USD | +1.58% |
|
-3.89% | +70.62% |
| 07:28am | Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target | MT |
| 06-30 | Candel Therapeutics Stock Gains on Launch of Phase 3 Trial for Lung-Cancer Drug | DJ |
| Market Cap | 695M 610M 565M 520M 983M 66.55B 1B 6.73B 2.64B 32.68B 2.61B 2.55B 113B | P/E 2026 * |
-10.6x | P/E 2027 * | -16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 695M 610M 565M 520M 983M 66.55B 1B 6.73B 2.64B 32.68B 2.61B 2.55B 113B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.2x |
| Free-Float |
84.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Candel Therapeutics, Inc.
| 1 day | +1.58% | ||
| 1 week | -3.89% | ||
| Current month | -6.41% | ||
| 1 month | +12.62% | ||
| 3 months | +97.95% | ||
| 6 months | +57.26% | ||
| Current year | +70.62% |
| 1 week | 9.19 |  | 10.27 |
| 1 month | 7.93 | | 11.36 |
| Current year | 4.44 | | 11.36 |
| 1 year | 4.35 | | 11.36 |
| 3 years | 0.66 | | 14.6 |
| 5 years | 0.66 | | 14.78 |
| 10 years | 0.66 | | 14.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 66 | 2020-08-31 |
Charles Schoch
DFI | Director of Finance/CFO | 41 | 2024-01-11 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 57 | 2022-09-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Benz
BRD | Director/Board Member | 80 | 2017-08-31 |
Paul-Peter Tak
BRD | Director/Board Member | 66 | 2020-08-31 |
Paul Manning
CHM | Chairman | 70 | 2021-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-05 | Free | Executive/Senior Manager | 285,000 | 0.3890% | ||
| 06-29 | Free | Chairman | 2,199 | 0.0030% | ||
| 06-29 | Free | Director | 381 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.58% | -3.89% | +49.92% | +703.33% | 695M | |
| +0.44% | +2.51% | +4.36% | +10.27% | 50.73B | |
| -1.57% | -3.18% | +379.41% | +593.37% | 39.73B | |
| -0.14% | +0.77% | +29.61% | -5.50% | 34.69B | |
| +1.76% | -1.78% | +20.55% | +53.38% | 33.21B | |
| -0.06% | -4.63% | +2.94% | +31.65% | 26.76B | |
| -1.93% | -1.01% | - | - | 16.8B | |
| -1.49% | -6.18% | +65.50% | +120.53% | 15.37B | |
| +0.78% | +0.20% | +14.69% | +17.08% | 13.78B | |
| -0.97% | -2.83% | +11.09% | -33.29% | 12.85B | |
| Average | -0.19% | -1.23% | +64.23% | +165.65% | 24.46B | |
| Weighted average by Cap. | -0.23% | -0.39% | +81.08% | +125.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 52.65M 46.18M 42.77M 39.35M 74.44M 5.04B 75.88M 510M 200M 2.47B 198M 193M 8.55B |
| Net income | -60.22M -52.82M -48.92M -45.01M -85.14M -5.76B -86.8M -583M -229M -2.83B -226M -221M -9.78B | -42.95M -37.67M -34.89M -32.1M -60.72M -4.11B -61.9M -416M -163M -2.02B -161M -158M -6.97B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | US$9.640 | +1.58% | 1,627,539 |
| 26-07-10 | US$9.490 | -4.04% | 1,190,965 |
| 26-07-09 | US$9.890 | +0.10% | 1,101,829 |
| 26-07-08 | US$9.880 | +0.30% | 1,945,023 |
| 26-07-07 | US$9.850 | -1.79% | 1,575,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CADL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
